West Family Investments Inc. Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

West Family Investments Inc. lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 943 shares of the medical equipment provider’s stock after selling 25 shares during the quarter. West Family Investments Inc.’s holdings in Intuitive Surgical were worth $492,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Ashton Thomas Private Wealth LLC grew its holdings in Intuitive Surgical by 153.5% in the 4th quarter. Ashton Thomas Private Wealth LLC now owns 2,241 shares of the medical equipment provider’s stock valued at $1,170,000 after buying an additional 1,357 shares during the period. Draper Asset Management LLC grew its holdings in Intuitive Surgical by 4.9% in the 4th quarter. Draper Asset Management LLC now owns 1,641 shares of the medical equipment provider’s stock valued at $884,000 after buying an additional 76 shares during the period. Callan Family Office LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $7,543,000. EagleClaw Capital Managment LLC grew its holdings in Intuitive Surgical by 8.2% in the 4th quarter. EagleClaw Capital Managment LLC now owns 2,380 shares of the medical equipment provider’s stock valued at $1,242,000 after buying an additional 180 shares during the period. Finally, E Fund Management Co. Ltd. grew its holdings in Intuitive Surgical by 106.0% in the 4th quarter. E Fund Management Co. Ltd. now owns 8,698 shares of the medical equipment provider’s stock valued at $4,540,000 after buying an additional 4,475 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares of the company’s stock, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 13,090 shares of company stock worth $7,496,119. 0.90% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Piper Sandler reiterated an “overweight” rating and set a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Evercore ISI boosted their target price on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Trading Down 5.2 %

Intuitive Surgical stock opened at $538.57 on Friday. The stock has a market cap of $191.83 billion, a P/E ratio of 84.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average of $571.70 and a 200-day moving average of $530.95. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.